Navigation Links
Journal of Clinical Oncology Publishes Study of Cephalon Medication TREANDA Plus Rituximab in Relapsed Non-Hodgkin's Lymphoma
Date:7/15/2008

Study Reports 92 Percent Response Rate to Combination Treatment

FRAZER, Pa., July 15 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) announced today that in a phase 2 study published online today in the Journal of Clinical Oncology, 92 percent of patients with relapsed indolent B-cell and mantle cell non-Hodgkin's lymphoma (NHL) responded to treatment with TREANDA(R) (bendamustine hydrochloride) for Injection plus rituximab. This combination study is one of three studies in patients with NHL that Cephalon submitted in December 2007 to the U.S. Food and Drug Administration requesting approval of TREANDA for the treatment of patients with indolent NHL who have progressed during or following treatment with rituximab or a rituximab-containing regimen. TREANDA was approved by the FDA in March 2008 for the treatment of patients with chronic lymphocytic leukemia and is not currently approved for use in NHL.

"A variety of treatment options have been employed in patients with indolent B-cell and mantle cell lymphomas, but resistance to treatment in this patient population often limits effective therapeutic options," said Dr. Charles Morris, Vice President, Worldwide Clinical Research at Cephalon. "Based on what we saw in this study, the combination of TREANDA with rituximab appears to elicit a high rate of durable responses and encouraging progression-free survival."

About the Study

In this multi-center, open-label, single arm, Phase 2 study, 66 patients with relapsed, indolent B-cell or mantle cell lymphoma without documented resistance to prior rituximab therapy were treated. Patients received rituximab 375 mg/meter squared intravenously on day one and TREANDA 90 mg/meter squared intravenously on days two and three of a 28-day cycle for up to six cycles. An additional dose of rituximab was given one week before the first cycle and four weeks after the last cycle.

Overall response rate was 92 percent with a complete respon
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Echo Therapeutics Announces Publication of Positive Clinical Data for its Symphony Transdermal Continuous Glucose Monitoring System in Journal of Diabetes Science and Technology
2. Complete Study Results Comparing CTIs OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology
3. Results Published in the Journal Cancer Demonstrate that Oral Talactoferrin Alfa is Active as Monotherapy in Previously Treated Patients with Metastatic Renal Cell Carcinoma
4. Journal of Clinical Oncology Publishes Leukine(R) Study Demonstrating Positive Survival Outcomes in Patients with High-Risk Melanoma
5. Journal of Antimicrobial Chemotherapy Paper Supports Additional Role for Cethromycin as Potential Treatment for Infections Caused by Community- Associated Methicillin Resistant Staphylococcus Aureus (CA-MRSA)
6. The Foundation for Biomedical Research Announces Winners of the 7th Annual Michael E. DeBakey Journalism Awards
7. The New England Journal of Medicine Publishes Study Investigating the Safety and Efficacy of Baxters Cell-Based Pandemic, Avian Flu Vaccine
8. Biopure Phase III Orthopedic Trial Results Published in Journal of Trauma
9. New England Journal of Medicine Publishes Results From a RELISTOR Phase 3 Clinical Study
10. Blood Spot Technology at ZRT Highlighted in March Issue of Journal of Diabetes Science & Technology - A Convenient Alternative to Serum Testing for Health Screening
11. Anesiva Announces Publication of Phase 3 Zingo(TM) Data in the Journal Pediatrics

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...swire/ -- Reportlinker.com announces that a new ma.... ,, Global Self Monitoring Blood Glucose Mark..., http://www.reportlinker.com/p0164657/Global-...asing-Adoption-to-Drive-Growth.html#utm_source=prn...ire ,, Description ,, Global Self Monitor...
(Date:11/20/2009)...swire/ -- ,, Reportlinker.com announces that a...talogue. ,, India Medical Equipment Market Ana...portlinker.com/p0164658/India-Medical-Equipment-Ma...e=prnewswire&utm_medium=pr&utm_campaign=pr... Equipment Market Analysis and Forecasts to 2015 ,...
(Date:11/20/2009)...swire/ -- Reportlinker.com announces that a new ma.... ,, Global Markets for Assisted Reproductive ...p0164742/Global-Markets-for-Assisted-Reproductive-...dium=pr&utm_campaign=prnewswire ,, Global..., 15 Countries in Europe and Japan. This report in...
Breaking Medicine Technology:Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 2Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 3Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 4Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 5Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 6Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 7Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 8Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 2Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 3Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 4Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 5Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 6Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 7Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 8Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 9Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 10Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 11Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 12Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 13Reportlinker Adds Global Markets for Assisted Reproductive Devices 2009 2Super sticky barnacle glue cures like blood clots 10391 1Super sticky barnacle glue cures like blood clots 10391 2Super sticky barnacle glue cures like blood clots 10391 3East Brunswick Native Returns Home to Help New Jersey Residents Living with MS 59610 1East Brunswick Native Returns Home to Help New Jersey Residents Living with MS 59610 2ECG for the mind could diagnose depression in an hour 14502 1ECG for the mind could diagnose depression in an hour 14502 2
...7 /PRNewswire/ -- MAP,Pharmaceuticals, Inc. today ...ts Unit Dose Budesonide (UDB) pediatric asthma the...at the Lutfi Kirdar,Convention and Exhibition Cent...entation entitled, "Efficacy and safety,of a novel...nebulized delivery in a 6 week study in 1-18 year ...
...cells with tumor lysate,triggers robust antigen-sp...AMA, Japan, June 22, 2007,/PRNewswire/ -- MaxCyte,...r presentation at the 13th Annual Meeting of the,I...ting is being,held June 24-27, 2007 in Sydney, Aus...ding of mature dendritic,cells with tumor lysate t...
Other Medicine Technology:MAP Pharmaceuticals to Present Unit Dose Budesonide Phase 2,Clinical Data at the World Asthma Meeting 2MaxCyte and Medinet to Present at the 13th Annual Meeting of the,International Society for Cellular Therapy (ISCT) in Sydney,Australia 2MaxCyte and Medinet to Present at the 13th Annual Meeting of the,International Society for Cellular Therapy (ISCT) in Sydney,Australia 3
(Date:11/21/2009)... New Haven Dental Group merges th... of Branford, CT. , (PRWE..., comprised of partners Dr. David Gibson, Dr. Dean...ster has just merged their growing practice with t..., ,When Dr. Pickman decided he wanted to retire fr...
(Date:11/20/2009)..., PRINCETON, NJ, Nov. 20 /PRNewswire-FirstCall/ ...at a Special Meeting of Shareholders will be held ...eeting is to consider approval of two special reso...e and authorize the sale of all or substantially a...terms provided for in the asset purchase agreement...
(Date:11/20/2009)..., QUINCY, Mass., Nov. 20 Followin...rket Company removed from sale Shedd,s Country Cro... and Shedd,s Country Crock ® Side Dishes DELU...allergen. ,, The following code dates and UPCs... Side Dishes DELUXE Cheddar Broccoli Rice 21 oz, U...
(Date:11/20/2009)..., CHICAGO, Nov. 20 The... U.S. Food and Drug Administration (FDA) to establ...g chemicals. ,, Citing concern about the safet...d without the benefit of professional consultation... that the application of chemically based tooth wh...
(Date:11/20/2009)..., WINSTON-SALEM, N.C., Nov. 20 /PRNewswire-USNews...on a mission to redefine what it means to be "happ... counselor with a specialty in family counseling a...orest University, Gladding says research shows tha...to sadness and even depression during the holidays...
Breaking Medicine News(10 mins):Health News:New Haven Dental Group Expands Their Vision 2Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2Health News:Why Holidays Don't Have To Be 'Happy' 2
...not comply with treatment instructions for osteopo...likely to suffer further fractures, which seriousl...nt need to provide support to these patients and a...e MRC Epidemiology Resource Centre, University of ...
...esearchers at Duke University Medical Center say t...harm to cardiovascular health in women than in men...Brain, Behavior and Immunity, found that poor slee.... They also found that these associations are sig...
...f., March 10 VoIP-PAL.com,Inc. (Pink Sheets: VPLM...(TM) and is pleased to report it has chosen the Ca...s its first recipient. Four,dollars from each tran...donate to,the Baldwin Foundation the 300 air miles...
...ould be left on, then removed as a unit once patie...lthDay News) -- During on-field treatment of young...t and shoulder pads should be kept on for initial ...d guidelines in the treatment of young (8 to 14 ye...
...ce is making many diseases increasingly difficult-...Anthony S. Fauci, M.D., director of the National I...), part of the National Institutes of Health. Exte...oblem that pose serious threats to domestic and gl...
...redential available in health education, ARLINGTO...g quality movement, the National Board for Profess...ed new assessments that will,accurately identify t...focusing on physical, mental, emotional,and social...
Other Medicine News:Health News:Make or break time for osteoporosis treatment 2Health News:Poor sleep more dangerous for women 2Health News:Poor sleep more dangerous for women 3Health News:VoIP-PAL.com, Inc. (Pink Sheets: VPLM.PK - News) UPDATE: Announces First Award Recipient of TalkfortheCure(TM) Dollars 2Health News:New Guidelines Urged for Young Athletes' Neck Injuries 2Health News:Confronting the challenge of antimicrobial resistance 2Health News:Confronting the challenge of antimicrobial resistance 3Health News:First-Ever National Board Certification(R) for America's Health Educators Arrives 2Health News:First-Ever National Board Certification(R) for America's Health Educators Arrives 3
Premier Mini-Drainable Pouch, Cut-to-Fit Flextend Skin Barrier, with Tape
Premier Lock 'n Roll Drainable Pouch, Cut-to-Fit Flextend Skin Barrier, with Tape
Premier Lock 'n Roll Drainable Pouch with Filter, Cut-to-Fit SoftFlex Skin Barrier
Premier Drainable Pouch, Cut-to-Fit Convex Flextend Skin Barrier, with Tape
Medicine Products: